Top Markets
#1 GALA GALA +34.47%
#2 Magma Finance Magma Finance +32.81%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +32.48%
#4 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +30.91%
#5 Bitcoin Cash Bitcoin Cash +30.80%
#6 Talus Network Talus Network +29.71%
#7 TROLL TROLL +28.68%
#8 Useless Coin Useless Coin +28.50%
#9 Bless Bless +28.17%
#10 Ethereum Name Service Ethereum Name Service +28.00%
Coin of the day
GALA GALA
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Achilles Therapeutics plc Achilles Therapeutics plc

Achilles Therapeutics plc

ACHL
Hisse Senetlerindeki Sıralama #24579
Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused... Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused on immuno-oncology. The firm specializes in creating innovative precision T-cell therapies designed to combat a range of solid tumors. Its primary therapeutic candidates, both currently undergoing Phase I/IIa clinical trials, are CHIRON, aimed at advanced non-small cell lung cancer, and THETIS, targeting metastatic or recurrent melanoma. Beyond these, Achilles is also advancing its pipeline with treatments for head and neck squamous cell carcinoma, renal cell carcinoma, triple-negative breast cancer, and bladder cancer. Initially incorporated as Achilles TX Limited, the company officially adopted the name Achilles Therapeutics Plc in February 2021. Established in 2016, its corporate headquarters are situated in London, United Kingdom.
Hisse Fiyatı
$1.48
Son senkronizasyon: 2025-03-24
Piyasa Değeri
$59.05M
Değişim (1 gün)
0.00%
Değişim (1 yıl)
0.00%
Ülke
GB
Ticaret Achilles Therapeutics plc (ACHL)

Kategori

Healthcare
Achilles Therapeutics plc (ACHL) için kazanç
2026 itibarıyla kazanç TTM: 0
Achilles Therapeutics plc şirketinin en son finansal raporlarına göre, mevcut kazancı 0'dir. 2026 yılında şirket 0 kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Achilles Therapeutics plc için kazanç geçmişi 2026 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH